Nuvig Therapeutics Inc. Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Nuvig Therapeutics is a biotechnology research company focused on developing novel immunomodulatory therapies aimed at restoring immune homeostasis and rebalancing immune function after inflammation, with the goal of improving treatment options for patients with chronic inflammatory and autoimmune diseases. Its work centers on building a pipeline of immune-focused therapeutics designed to modulate the immune system in ways that may benefit individuals suffering from inflammatory conditions. Based in Menlo Park, California, the company operates in the biotechnology research sector and has a footprint that positions it within the California life sciences community, collaborating in a field that seeks to translate immunology insights into new treatment approaches. Recent organizational changes include leadership appointments and governance updates, alongside ongoing participation in scientific meetings where its investigational agent NVG-2089 for CIDP has been showcased, illustrating its active clinical exploration and industry engagement.